US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.830
- -0.170-1.89%
Trading Nov 27 14:18 ET
172.46MMarket Cap-6060P/E (TTM)
9.180High8.600Low46.50KVolume9.180Open9.000Pre Close411.82KTurnover1.66%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High32.23P/B24.72MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM6.44%Amplitude5.510Historical Low8.856Avg Price1Lot Size
Actuate Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||||
| Gross profit | |||||||||
| Operating expense | -16.72%5.39M | -2.67%5.44M | 46.71%7.77M | 23.59%24.97M | 7.62M | 6.48M | 5.58M | 5.3M | 20.21M |
| Selling and administrative expenses | 129.05%1.64M | 31.65%1.06M | 17.81%912.82K | -14.51%3.27M | --969.35K | --714.17K | --807.18K | --774.8K | --3.82M |
| -General and administrative expense | 129.05%1.64M | 31.65%1.06M | 17.81%912.82K | -14.51%3.27M | --969.35K | --714.17K | --807.18K | --774.8K | --3.82M |
| Research and development costs | -34.79%3.76M | -8.47%4.37M | 51.65%6.86M | 32.47%21.71M | --6.65M | --5.76M | --4.78M | --4.52M | --16.39M |
| Operating profit | 16.72%-5.39M | 2.67%-5.44M | -46.71%-7.77M | -23.59%-24.97M | -7.62M | -6.48M | -5.58M | -5.3M | -20.21M |
| Net non-operating interest income expense | -36.09%77.26K | -96.77%3.57K | -58.14%9.71K | 2,754.26%309.03K | 54.63K | 120.88K | 110.33K | 23.2K | 10.83K |
| Non-operating interest income | -35.89%80.75K | -92.51%8.65K | -71.37%14.79K | 1,204.89%352.67K | --59.69K | --125.94K | --115.39K | --51.65K | --27.03K |
| Non-operating interest expense | -31.07%3.49K | 0.28%5.08K | -82.16%5.08K | 169.39%43.64K | --5.06K | --5.06K | --5.06K | --28.45K | --16.2K |
| Other net income (expense) | -3,985.43%-655.32K | -2,171.86%-1.14M | -10,533.29%-532.52K | -318.22%-79.82K | -51.6K | 16.87K | -50.19K | 5.1K | 36.58K |
| Gain on sale of security | 3,085.05%537.19K | -378.82%-240.34K | -737.05%-32.52K | -318.22%-79.82K | ---51.6K | --16.87K | ---50.19K | --5.1K | --36.58K |
| Other non- operating income (expenses) | ---1.19M | ---900K | ---500K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 5.79%-5.97M | -18.97%-6.57M | -57.41%-8.3M | -22.74%-24.74M | -7.61M | -6.34M | -5.52M | -5.27M | -20.16M |
| Income tax | |||||||||
| Net income | 5.79%-5.97M | -18.97%-6.57M | -57.41%-8.3M | -22.74%-24.74M | -7.61M | -6.34M | -5.52M | -5.27M | -20.16M |
| Net income continuous Operations | 5.79%-5.97M | -18.97%-6.57M | -57.41%-8.3M | -22.74%-24.74M | ---7.61M | ---6.34M | ---5.52M | ---5.27M | ---20.16M |
| Minority interest income | |||||||||
| Net income attributable to the parent company | 5.79%-5.97M | -18.97%-6.57M | -57.41%-8.3M | -22.74%-24.74M | -7.61M | -6.34M | -5.52M | -5.27M | -20.16M |
| Preferred stock dividends | |||||||||
| Other preferred stock dividends | |||||||||
| Net income attributable to common stockholders | 5.79%-5.97M | -18.97%-6.57M | -57.41%-8.3M | -22.74%-24.74M | -7.61M | -6.34M | -5.52M | -5.27M | -20.16M |
| Basic earnings per share | -34.42%-0.55 | 3.58%-0.3439 | -58.71%-0.54 | -23.05%-1.65 | -0.3983 | -0.4092 | -0.3566 | -0.3402 | -1.3409 |
| Diluted earnings per share | -34.42%-0.55 | 3.58%-0.3439 | -58.71%-0.54 | -23.05%-1.65 | -0.3983 | -0.4092 | -0.3566 | -0.3402 | -1.3409 |
| Dividend per share | |||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
